• About WordPress
    • WordPress.org
    • Documentation
    • Learn WordPress
    • Support
    • Feedback
  • Log In
  • Register
Skip to content
Endocannabinoid Science Education Endocannabinoid Science Education

ECS is Physiology

  • What?
  • Why?
  • How?
  • Where?
  • Contact
  • Advisory Board
  • Forums
  • Blog
  • Bio
  • ECS Explained
Endocannabinoid Science Education
Endocannabinoid Science Education

ECS is Physiology

Category: Scientific Summary

Endocannabinoid System (ECS) Blog header illustration for how an omega-3 RCT reveals a hidden layer of presumed ECS restoration. ECS.education logotype visible to the right.

Why an Omega-3 Trial for Anxiety Accidentally Proved Something Far More Interesting About Your Endocannabinoid System

Posted on March 16, 2026March 16, 2026 By Stefan Broselid

A new randomised, double-blind, placebo-controlled trial published in the Journal of Affective Disorders set out to test whether omega-3 supplementation improves stress, anxiety, depression, sleep quality, and memory in people with severe psychological distress (Azhar et al., 2025). The trial was conducted on a Saudi population, was reasonably well-designed, and produced striking…

Read more
Endocannabinoid System (ECS)

Your ECS Under Load: Regular Cannabis, Exercise, and a Blunted Runner’s High

Posted on March 2, 2026March 2, 2026 By Stefan Broselid

Your ECS under load, not at rest Most cannabis conversations live in the acute space: “How does it feel when I’m high?” or in vague long‑term boxes like “motivation” or “psychosis risk.” Almost nobody asks the more mechanistic question that actually matters for resilience:​ What does your endocannabinoid system do…

Read more
Endocannabinoid System (ECS) Three-panel scientific illustration comparing endocannabinoid system function across three dietary states. Left panel: High omega-6 diet showing excess CB1 receptor stress and 2-AG/AEA production (omega-6:omega-3 ratio 20:1). Center panel: Optimized substrates with balanced membrane composition supporting multiple endocannabinoid types and receptor function. Right panel: High omega-3 diet showing activated TRPV1/TRPA1 ion channels, PPARα activation, and anti-inflammatory endocannabinoid production (omega-3:omega-6 ratio 4:1). Bottom tagline: Substrate availability dictates endocannabinoid system function.

2025 in ECS Research: The Year the Substrate-Driven ECS Model Came of Age

Posted on December 28, 2025December 28, 2025 By Stefan Broselid

Endocannabinoid system substrate—specifically membrane fatty acid composition—is the primary determinant of CB1 receptor function, not genetics or receptor density. For years, I’ve been making the case that endocannabinoid system function is not primarily about receptor density or genetic variants, it’s about substrate availability. The composition of fatty acids in cell…

Read more
Commentary Header graphic for an ECS.education article titled ‘When Percentages Lie: Rethinking Omega‑6 Risk Biomarkers’. Two simple scatter‑plot cartoons show linoleic‑acid–related cardiometabolic risk: on the left, risk plotted against LA in µmol/L with a bold red arrow sloping up; on the right, risk plotted against LA as percent of total fatty acids with a bold green arrow sloping down, illustrating how concentration and percentage give opposite trends. On the far right, a clear plastic bottle pours golden cooking oil next to a linoleic acid structural formula and the ECS.education logo, with the study DOI printed near the top.

When Percentages Lie: Rethinking Omega‑6 (LA & AA) Risk Biomarkers and Endocannabinoid Substrates

Posted on December 4, 2025December 4, 2025 By Stefan Broselid

The blind spot in fatty acid epidemiology Since the 1960s, most circulating fatty acid data have been reported as “percent of total” rather than as absolute concentrations, because gas chromatography methods naturally produce compositional peak areas that are easy to turn into percentages (Sergeant et al., 2016; Lagerstedt et al.,…

Read more
Endocannabinoid System (ECS) Soybean oil and linoleic acid tipping gut lipid balance: diagram showing linoleic acid driving arachidonic acid toward eicosanoids while endocannabinoids decrease, with a bottle of soybean oil and soybeans.

Soybean oil, linoleic acid, and the gut ECS

Posted on September 19, 2025September 19, 2025 By Stefan Broselid

A recent study titled ‘Diet high in linoleic acid dysregulates the intestinal endocannabinoid system and increases susceptibility to colitis in Mice‘ shows that eating a lot of linoleic acid from soybean oil changes lipid chemistry in the gut in a way that weakens the protective endocannabinoid system and strengthens inflammatory…

Read more
Endocannabinoid System (ECS) Illustration showing the link between obesity and dysfunction in the endocannabinoid system (ECS). The image includes a silhouette of an overweight person, a fingerprint, a brain with a cannabis leaf symbol, and a chemical structure with the text 'ECS.education'

Obesity’s metabolic fingerprint is characterised by ECS Dysfunction!

Posted on August 2, 2025 By Stefan Broselid

Obesity isn’t just about extra weight—it imprints a unique metabolic fingerprint deep within your body. New research reveals that this signature is marked by endocannabinoid system (ECS) dysfunction, driven by dietary fat balance and energy surplus. Learn how what you eat tunes your ECS, shapes your health risks, and why fixing the “input side” of nutrition could help fade the metabolic fingerprint of obesity.

Read more
Endocannabinoid System (ECS) Illustration of an overweight person sitting next to a stylized neuron and molecular structures, visually representing the concept that obesity rewires the endocannabinoid system.

Obesity Rewires Your Endocannabinoid System (ECS): How Fat, Liver, Heart & Brain Are Transformed

Posted on June 17, 2025 By Stefan Broselid

Obesity is more than excess fat—it’s a disorder of endocannabinoid system (ECS) dysfunction. Explore how obesity rewires CB1 signaling in fat, liver, heart, and brain, driving chronic disease.

Read more
Endocannabinoid System (ECS) Paracetamol as an Analgesic DAGL Inhibitor – Mechanism Confirmed by Jesus et al. 2025 Preprint

Paracetamol Confirmed as a Direct Analgesic DAGL Inhibitor: New Preprint Evidence

Posted on June 4, 2025June 4, 2025 By Stefan Broselid

Important Note: This blog post discusses findings from a recent scientific preprint, meaning the research has not yet been formally peer-reviewed. Preprints allow for rapid dissemination of findings, but results should be interpreted cautiously until confirmed by peer-reviewed publication. Recently, we reported on a surprising new way that paracetamol (also known…

Read more
Nutrition Science Conceptual image illustrating how maternal adiposity influences breast milk PUFA levels (like DHA & AA) and impacts infant endocannabinoid system (ECS) development.

The Adiposity Filter: How Maternal Body Fat Reshapes Milk PUFAs for Your Baby’s ECS

Posted on May 23, 2025May 23, 2025 By Stefan Broselid

At ECS.education, we’ve previously delved into how maternal metabolism and milk composition program infant development, the profound impact of maternal diet on the endocannabinoidome and infant health, and the links between ECS dysfunction, conditions like autism, and metabolic syndrome. Today, we explore compelling new research that adds another crucial layer to this understanding:…

Read more
Endocannabinoid System (ECS) Chemical structure of Agmatine overlaid on a micrograph, with text: The Agmatine-ECS Connection - New Hope for ASD by Boosting 2-AG and Calming the Brain.

The Agmatine-ECS-ASD Connection: New Hope for ASD by Boosting 2-AG and Calming the Brain

Posted on May 22, 2025May 22, 2025 By Stefan Broselid

Explore groundbreaking research on agmatine’s connection to the endocannabinoid system (ECS) in Autism (ASD). Discover how it may boost 2-AG, calm brain inflammation, and offer new hope for understanding and potentially supporting ASD.

Read more
  • 1
  • 2
  • …
  • 4
  • Next
©2026 Endocannabinoid Science Education | WordPress Theme by SuperbThemes